Related Experiment Videos
Secreted euryarchaeal microhalocins kill hyperthermophilic crenarchaea.
C Haseltine1, T Hill, R Montalvo-Rodriguez
1University of Nebraska, Lincoln 68588-0666, USA.
Journal of Bacteriology
|December 15, 2000
Summary
Archaea produce novel peptide antibiotics called halocins that are toxic to other archaea, not bacteria or eukaryotes. These halocins show potential for genetic manipulation of archaeal species like Sulfolobus.
Area of Science:
- Microbiology
- Biochemistry
- Genetics
Background:
- Limited availability of antibiotics for archaeal genetic studies.
- Bacterial antibiotics often target related organisms, suggesting archaea may produce antiarchaeal compounds.
Purpose of the Study:
- Investigate archaeal-derived antibiotics (halocins) for antiarchaeal activity.
- Assess the potential of halocins for genetic manipulation of archaea, specifically Sulfolobus.
Main Methods:
- Screening of halocin preparations from Euryarchaeota strains against Crenarchaeota (Sulfolobus).
- Determining cytostatic vs. cytocidal effects of halocins.
- Biochemical analysis (protease, nuclease treatment) to identify the toxic factor.
- Assessing salt-dependency of toxicity.
- Inducing and isolating UV-resistant mutants of Sulfolobus.
Main Results:
- Halocin preparations from Euryarchaeota were toxic to Sulfolobus (Crenarchaeota), with no effect on bacteria or eukaryotes.
- Halocin A4 was cytocidal, and its toxic factor was identified as a secreted protein.
- Toxicity was potentiated by potassium chloride, indicating a salt-dependent mechanism.
- UV-induced resistant mutants of Sulfolobus were isolated, exhibiting stable phenotypes.
Conclusions:
- Archaea-derived halocins represent a novel class of antibiotics effective against other archaea.
- Halocin A4 shows promise for the genetic manipulation of Sulfolobus.
- The salt-dependent mechanism of halocin toxicity warrants further investigation.